Preferences help
enabled [disable] Abstract
Number of results
2006 | 53 | 4 | 641-650
Article title

Thyroid hormones and their receptors in the regulation of cell proliferation

Title variants
Languages of publication
In the present work, we have reviewed data showing that triiodothyronine and its nuclear receptors modify expression of different genes/proteins involved in cell cycle control beginning from growth factors (such as EGF and TGF-β), to cell surface receptors (EGFR), as well as proteins acting at the cell membrane (Ras), various transcription factors (c-Fos, c-Myc, E2F1), cyclins, Cip/Kip family of cdk2 inhibitors, and p53 inhibitor Mdm2 (Table 1). We have shown how TRs are also able to modify the fate of a cell, thanks to their ability to form complexes with other transcription factors such as p53 - a key regulator of apoptosis and proliferation. Available data show that the function of thyroid hormones and of their receptors on cell proliferation is not homogenous. In fact, it strongly depends on the cell type, its developmental state (progenitor or differentiated), its patho-physiological state (normal or tumor cell), and the so-called 'cellular context'. Therefore, it is not possible to uniformly recommend T3 treatment or T3 depletion to stop or initiate proliferation of all cell types. Instead, a very individual and careful action should be considered.
Physical description
  • Department of Endocrinology, Medical Research Center, Polish Academy of Sciences, Warszawa, Poland
  • Department of Endocrinology, Medical Research Center, Polish Academy of Sciences, Warszawa, Poland
  • Department of Biochemistry and Molecular Biology, Medical Center of Postgraduate Education, Warszawa, Poland
  • Department of Biochemistry and Molecular Biology, Medical Center of Postgraduate Education, Warszawa, Poland
  • Alisi A, Demori I, Spagnuolo S, Pierantozzi E, Fugassa E, Leoni S (2005) Thyroid status affects rat liver regeneration after partial hepatectomy by regulating cell cycle and apoptosis. Cell Physiol Biochem 15: 69-76.
  • Amati B, Frank SR, Donjerkovic D, Taubert S (2001) Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471: M135-M145.
  • Attwooll C, Lazzerini Denchi E, Helin K (2004) The E2F family: specific functions and overlapping interests. EMBO J 23: 4709-4716.
  • Baas D, Bourbeau D, Sarlieve LL, Ittel ME, Dussault JH, Puymirat J (1997) Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia 19: 324-332.
  • Bachman KE, Park BH (2005) Duel nature of TGF-β signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 17: 49-54.
  • Barrera-Hernandez G, Zhan Q, Wong R, Cheng SY (1998) Thyroid hormone receptor is a negative regulator in p53-mediated signaling pathways. DNA Cell Biol 17: 743-750.
  • Barrera-Hernandez G, Park KS, Dace A, Zhan Q, Cheng SY (1999) Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 140: 5267-5274.
  • Bassett JH, Harvey CB, Williams GR (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213: 1-11.
  • Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G, Beug H (1998) The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors. EMBO J 17: 4291-4303.
  • Bernal J (2005) Pathophysiology of thyroid hormone deficiency during fetal development. J Pediatr Endocrinol Metab 18 (Suppl 1): 1253-1256.
  • Bernard S, Eilers M (2006) Control of cell proliferation and growth by Myc proteins. Results Probl Cell Differ 42: 329-342.
  • Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR (2002) Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23: 38-89.
  • Buzzard JJ, Wreford NG, Morrison JR (2003) Thyroid hormone, retinoic acid, and testosterone suppress proliferation and induce markers of differentiation in cultured rat Sertoli cells. Endocrinology 144: 3722-3731.
  • Cadwell C, Zambetti GP (2001) The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 277: 15-30.
  • Carpenter G, Cohen S (1990) Epidermal growth factor. J Biol Chem 265: 7709-7712.
  • Carr FE, Wong NC (1994) Characteristics of a negative thyroid hormone response element. J Biol Chem 269: 4175-4179.
  • Chatterjee VK, Lee JK, Rentoumis A, Jameson JL (1989) Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci USA 86: 9114-9118.
  • Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
  • Chen J, Wu X, Lin J, Levine AJ (1996) Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 16: 2445-2452.
  • Chen SL, Chang YJ, Wu YH, Lin KH (2003) Mitogen-activated protein kinases potentiate thyroid hormone receptor transcriptional activity by stabilizing its protein. Endocrinology 144: 1407-1419.
  • Cheng SY (2000a) Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. In Reviews in Endocrine and Metabolic Disorders (LeRoith D, ed) pp 9-18. Kluwer Academic, New York, NY.
  • Cheng SY (2004b) Abnormalities of nuclear receptors in thyroid cancer. Cancer Treat Res 122: 165-178.
  • Cheng SY (2005) Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance. Trends Endocrinol Metab 16: 176-182.
  • Cheng SY (2005) Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice. Steroids 70: 450-454.
  • Cole MD, Nikiforov MA (2006) Transcriptional activation by the Myc oncoprotein. Curr Top Microbiol Immunol 302: 33-50.
  • Crespo P, Leon J (2000) Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol Life Sci 57: 1613-1636.
  • Di Fulvio M, Coleoni AH, Pellizas CG, Masini-Repiso AM (2000) Tri-iodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factor-associated tyrosine kinase activity. J Endocrinol 166: 173-182.
  • Dinda S, Sanchez A, Moudgil V (2002) Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 21: 761-768.
  • Eckey M, Moehren U, Baniahmad A (2003) Gene silencing by the thyroid hormone receptor. Mol Cell Endocrinol 213: 13-22.
  • Foster MP, Montecino-Rodriguez E, Dorshkind K (1999) Proliferation of bone marrow pro-B cells is dependent on stimulation by the pituitary/thyroid axis. J Immunol 163: 5883-5890.
  • Francavilla A, Carr BI, Azzarone A, Polimeno L, Wang Z, Van Thiel DH, Subbotin V, Prelich JG, Starzl TE (1994) Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 20: 1237-1241.
  • Fu M, Wang C, Li Z, Sakamaki T, Pestell RG (2004) Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447.
  • Fujieda M, Murata Y, Hayashi H, Kambe F, Matsui N, Seo H (1993) Effect of thyroid hormone on epidermal growth factor gene expression in mouse submandibular gland. Endocrinology 132: 121-125.
  • Garcia-Silva S, Aranda A (2004) The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24: 7514-7523.
  • Garcia-Silva S, Perez-Juste G, Aranda A (2002) Cell cycle control by the thyroid hormone in neuroblastoma cells. Toxicology 181/182: 179-182.
  • Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12: 1173-1180.
  • Gonzalez-Sancho JM, Figueroa A, Lopez-Barahona M, Lopez E, Beug H, Munoz A (2002) Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells. Mol Carcinog 34: 25-34.
  • Green NK, Gammage MD, Franklyn JA, Sheppard MC (1991) Regulation by thyroid status of c-myc, c-fos and H-ras mRNAs in the rat myocardium. J Endocrinol 130: 239-244.
  • Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98: 859-869.
  • Helin K (1998) Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8: 28-35.
  • Hess J, Angel P, Schorpp-Kistner M (2004) AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117: 5965-5973.
  • Holsberger DR, Jirawatnotai S, Kiyokawa H, Cooke PS (2003) Thyroid hormone regulates the cell cycle inhibitor p27Kip1 in postnatal murine Sertoli cells. Endocrinology 144: 3732-3738.
  • Humes HD, Cieslinski DA, Johnson LB, Sanchez IO (1992) Triiodothyronine enhances renal tubule cell replication by stimulating EGF receptor gene expression. Am J Physiol 262: F540-F545.
  • Johnson DG, Schwarz JK, Cress WD, Nevins JR (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352.
  • Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, Nauman A (2002) Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23: 25-33.
  • Kassem M, Mosekilde L, Eriksen EF (1993) Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro. Biochem Mol Biol Int 30: 779-788.
  • Kozar K, Sicinski P (2005) Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 4: 388-391.
  • Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303.
  • Ledda-Columbano GM, Perra A, Pibiri M, Molotzu F, Columbano A (2005) Induction of pancreatic acinar cell proliferation by thyroid hormone. J Endocrinol 185: 393-399.
  • Ledda-Columbano GM, Molotzu F, Pibiri M, Cossu C, Perra A, Columbano A (2006) Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes. FASEB J 20: 87-94.
  • Lemkine GF, Raj A, Alfama G, Turque N, Hassani Z, Alegria-Prevot O, Samarut J, Levi G, Demeneix BA (2005) Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor. FASEB J 19: 863-865.
  • Leveillard T, Wasylyk B (1997) The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter. J Biol Chem 272: 30651-30661.
  • Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
  • Lin HY, Hopkins R, Cao HJ, Tang HY, Alexander C, Davis FB, Davis PJ (2005) Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism. Steroids 70: 444-449.
  • Malik R, Mellor N, Selden C, Hodgson H (2003) Triiodothyronine enhances the regenerative capacity of the liver following partial hepatectomy. Hepatology 37: 79-86.
  • Manteuffel-Cymborowska M (1999) Nuclear receptors, their coactivators and modulation of transcription. Acta Biochim Polon 46: 77-89.
  • Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T (1995) Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375: 691-694.
  • Martinez R, Gomes FC (2002) Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins. J Biol Chem 277: 49311-49318.
  • Martinez R, Gomes FC (2005) Proliferation of cerebellar neurons induced by astrocytes treated with thyroid hormone is mediated by a cooperation between cell contact and soluble factors and involves the epidermal growth factor-protein kinase a pathway. J Neurosci Res 80: 341-349.
  • Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ (1992) Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71: 323-334.
  • McKenna NJ, Lanz RB, O'Malley BW (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20: 321-344.
  • Mercier G, Turque N, Schumacher M (2001) Rapid effects of triiodothyronine on immediate-early gene expression in Schwann cells. Glia 35: 81-89.
  • Meyerson M, Harlow E (1994) Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14: 2077-2086.
  • Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7: 1191-1204.
  • Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
  • Moore JM, Guy RK (2005) Coregulator interactions with the thyroid hormone receptor. Mol Cell Proteomics 4: 475-842.
  • Morreale de Escobar G, Obregon MJ, Escobar del Rey F (2004) Role of thyroid hormone during early brain development. Eur J Endocrinol 151 (Suppl 3): U25-U37.
  • North S, Hainaut P (2000) p53 and cell-cycle control: a finger in every pie. Pathol Biol 48: 255-270.
  • Nygard M, Wahlstrom GM, Gustafsson MV, Tokumoto YM, Bondesson M (2003) Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol Endocrinol 17: 79-92.
  • Ohmura T, Katyal SL, Locker J, Ledda-Columbano GM, Columbano A, Shinozuka H (1997) Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3',5-triiodo-L-thyronine. Cancer Res 57: 795-798.
  • Onate SA, Tsai SY, Tsai MJ, O'Malley BW (1995) Sequence and characterization of coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
  • Palmero S, Prati M, Bolla F, Fugassa E (1995) Tri-iodothyronine directly affects rat Sertoli cell proliferation and differentiation. J Endocrinol 145: 355-362.
  • Perez P, Schonthal A, Aranda A (1993) Repression of c-fos gene expression by thyroid hormone and retinoic acid receptors. J Biol Chem 268: 23538-23543.
  • Perez P, Palomino T, Schonthal A, Aranda A (1994) Determination of the promoter elements that mediate repression of c-fos gene transcription by thyroid hormone and retinoic acid receptors. Biochem Biophys Res Commun 205: 135-140.
  • Perez-Juste G, Aranda A (1999) The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. J Biol Chem 274: 5026-5031.
  • Perez-Juste G, Garcia-Silva S, Aranda A (2000) An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells. J Biol Chem 275: 1307-1314.
  • Pibiri M, Ledda-Columbano GM, Cossu C, Simbula G, Menegazzi M, Shinozuka H, Columbano A (2001) Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J 15: 1006-1013.
  • Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J (2002) Functionally impaired thyroid hormone receptor mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87: 1120-1128.
  • Qi JS, Desai-Yajnik V, Yuan Y, Samuels HH (1997) Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression. Mol Cell Biol 17: 7195-7207.
  • Qi JS, Yuan Y, Desai-Yajnik V, Samuels HH (1999) Regulation of the mdm2 oncogene by thyroid hormone receptor. Mol Cell Biol 19: 864-872.
  • Radoja N, Diaz DV, Minars TJ, Freedberg IM, Blumenberg M, Tomic-Canic M (1997) Specific organization of the negative response elements for retinoic acid and thyroid hormone receptors in keratin gene family. J Invest Dermatol 109: 566-572.
  • Rastinejad F (2001) Retinoid X receptor and its partners in the nuclear receptor family. Curr Opin Struct Biol 11: 33-38.
  • Sadow PM, Chassande O, Gauthier K, Samarut J, Xu J, O'Malley BW, Weiss RE (2003) Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action. Am J Physiol Endocrinol Metab 284: E36-E46.
  • Safer JD, Crawford TM, Holick MF (2005) Topical thyroid hormone accelerates wound healing in mice. Endocrinology 146: 4425-4430.
  • Sakurai A, Nakai A, DeGroot LJ (1989) Expression of three forms of thyroid hormone receptor in human tissues. Mol Endocrinol 3: 392-399.
  • Sasaki S, Lesoon-Wood LA, Dey A, Kuwata T, Weintraub BD, Humphrey G, Yang WM, Seto E, Yen PM, Howard BH, Ozato K (1999) Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin β gene. EMBO J 18: 5389-5398.
  • Schrader M, Carlberg C (1994) Thyroid hormone and retinoic acid receptors form heterodimers with retinoid X receptors on direct repeats, palindromes and inverted palindromes. DNA Cell Biol 13: 333-341.
  • Shahrara S, Drvota V, Sylven C (1999) Organ specific expression of thyroid hormone receptor mRNA and protein in different human tissues. Biol Pharm Bull 22: 1027-1033.
  • Sherr CJ (1993) Mammalian G1 cyclins. Cell 73: 1059-1065.
  • Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60: 3689-3695.
  • Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711.
  • Shi Y (2001) Structural insights on Smad function in TGFbeta signaling. Bioessays 23: 223-232.
  • Shibusawa N, Hollenberg AN, Wondisford FE (2003) Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J Biol Chem 278: 732-738.
  • Shih A, Lin HY, Davis FB, Davis PJ (2001) Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40: 2870-2878.
  • Su Y, Damjanovski S, Shi Y, Shi YB (1999) Molecular and cellular basis of tissue remodeling during amphibian metamorphosis. Histol Histopathol 14: 175-183.
  • Szanto A, Narkar V, Shen Q, Uray IP, Davies PJ, Nagy L (2004) Retinoid X receptors: X-ploring their (patho)physiological functions. Cell Death Differ 11 (Suppl 2): S126-S143.
  • Toms SA, Hercbergs A, Liu J, Kondo S, Barnett GH, Casey G, Barna BP (1998) Thyroid hormone depletion inhibits astrocytoma proliferation via a p53-independent induction of p21 (WAF1/CIP1). Anticancer Res 18: 289-293.
  • Trentin AG, Alvarez-Silva M, Moura Neto V (2001) Thyroid hormone induces cerebellar astrocytes and C6 glioma cells to secrete mitogenic growth factors. Am J Physiol Endocrinol Metab 281: E1088-E1094.
  • Tulchinsky E (2000) Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol 15: 921-928.
  • Weiss RE, Ramos HE (2004) Thyroid hormone receptor subtypes and their interaction with steroid receptor coactivators. Vitam Horm 68: 185-207.
  • Williams GR, Robson H, Shalet SM (1998) Thyroid hormone actions on cartilage and bone: interactions with other hormones at the epiphyseal plate and effects on linear growth. J Endocrinol 157: 391-403.
  • Wolffe AP, Collingwood TN, Li Q, Yee J, Urnov F, Shi YB (2000) Thyroid hormone receptor, v-ErbA, and chromatin. Vitam Horm 58: 449-492.
  • Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G (2001) The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414: 457-462.
  • Van Zoelen EJ, Stortelers C, Lenferink AE, Van de Poll ML (2000) The EGF domain: requirements for binding to receptors of the ErbB family. Vitam Horm 59: 99-131.
  • Vidal A, Koff A (2000) Cell-cycle inhibitors: three families united by a common cause. Gene 247: 1-15.
  • Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698.
  • Yap N, Yu CL, Cheng SY (1996) Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc Natl Acad Sci USA 93: 4273-4277.
  • Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
  • Yen PM, Cheng SY (2003) Germline and somatic thyroid hormone receptor mutations in man. J Endocrinol Invest 26: 780-787.
  • Yen CC, Huang YH, Liao CY, Liao CJ, Cheng WL, Chen WJ, Lin KH (2006) Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. J Mol Endocrinol 36: 9-21.
  • Zhang J, Lazar MA (2000) The mechanism of action of thyroid hormones. Annu Rev Physiol 62: 439-466.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.